Form 4: Quest Diagnostics SVP Michael Prevoznik Reports Stock Transactions

Michael E. Prevoznik, SVP & General Counsel of Quest Diagnostics, reports acquisition and disposition of common stock related to a performance share award.

Summary

• On February 23, 2024, Michael E. Prevoznik, SVP & General Counsel of Quest Diagnostics, reported transactions involving the company's common stock.
• He acquired 7,569 shares at a price of $125.02 per share as settlement of a performance share award dated February 18, 2021.
• He disposed of 2,825 shares at $125.02 per share to cover tax withholding obligations related to the settlement.
• Following these transactions, Prevoznik directly owns 44,950 shares of common stock.
• He also indirectly owns 5,541 shares through the company's 401(k)/SDCP.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation. There are no explicit positive or negative implications for the company's performance.

Positives

• The acquisition of shares reflects the vesting of a performance share award, suggesting the achievement of certain performance metrics.

Negatives

• The disposition of shares to cover tax obligations reduces the number of shares directly held by the reporting person.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding executive compensation and ownership.

Key Dates